Perrigo (NYSE:PRGO) Rating Lowered to "Hold" at Wall Street Zen

Key Points

• Wall Street Zen downgraded Perrigo from “Buy” to “Hold.” The broader analyst consensus is also “Hold,” with one Buy, four Hold and one Sell rating, and a consensus price target of $17.50.
• Perrigo reported quarterly EPS of $0.50, exceeding the $0.39 analyst estimate, while revenue came in at $1.02 billion, down 3.1% year over year. The company guided to fiscal 2026 EPS of $2.25–$2.55.
• The stock opened at $15.78 and has gained from its 52-week low of $9.23, but remains below its 52-week high of $21.01. Institutional investors own approximately 95.91% of Perrigo’s shares.

Perrigo (NYSE:PRGO - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings upgraded Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Perrigo presently has a consensus rating of "Hold" and a consensus price target of $17.50.

Perrigo Stock Down 0.8%

Shares of PRGO opened at $15.78 on Friday. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.32 and a current ratio of 2.32. Perrigo has a one year low of $9.23 and a one year high of $21.01. The stock has a market capitalization of $2.19 billion, a price-to-earnings ratio of -1.26, a PEG ratio of 1.83 and a beta of 0.69. The stock has a 50 day moving average price of $14.83 and a 200 day moving average price of $12.48.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the firm posted ($0.06) EPS. The firm's revenue for the quarter was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts forecast that Perrigo will post 2.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Covestor Ltd raised its stake in shares of Perrigo by 13.1% during the third quarter. Covestor Ltd now owns 7,748 shares of the company's stock worth $114,000 after purchasing an additional 897 shares during the last quarter. Salomon & Ludwin LLC acquired a new position in shares of Perrigo during the third quarter worth about $25,000. Profund Advisors LLC raised its holdings in Perrigo by 288.3% during the third quarter. Profund Advisors LLC now owns 113,418 shares of the company's stock worth $1,674,000 after purchasing an additional 84,207 shares in the last quarter. ProShare Advisors LLC raised its holdings in Perrigo by 51.7% during the third quarter. ProShare Advisors LLC now owns 959,053 shares of the company's stock worth $14,156,000 after purchasing an additional 326,797 shares in the last quarter. Finally, Vise Technologies Inc. lifted its position in Perrigo by 77.3% in the third quarter. Vise Technologies Inc. now owns 22,352 shares of the company's stock valued at $330,000 after purchasing an additional 9,747 shares during the period. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Company Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women's health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.